Female sexual dysfunction and use of hormone therapy in postmenopausal women

Seminars in Reproductive Medicine

Volumn 23, Issue 2, 2005, Pages 180-187

  Kovalevsky, George ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Androgens; Female sexual dysfunction; Hormone therapy; Postmenopausal

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GLUCOCORTICOID; METHYLTESTOSTERONE; PLACEBO; PRASTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TESTOSTERONE; TIBOLONE;

ANDROGEN DEFICIENCY; CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; DYSPAREUNIA; EMOTION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; MENOPAUSE; POSTMENOPAUSE; REVIEW; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; VAGINA ATROPHY;

ANDROGENS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; POSTMENOPAUSE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 18044381725     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-869486     Document Type: Review

References (36)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544
2. Masters W, Johnson V. Human Sexual Response. Boston: Little, Brown; 1966
3. Basson R. Human sex-response cycles. J Sex Marital Ther 2001;27:33-43
4. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888-893
5. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456-460
6. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;77(suppl 4):S42-S48
7. Morrell M, Dixen J, Carter C, Davidson J. The influence of age and cycling status on sexual arousabiliry in women. Am J Obstet Gynecol 1984;148:66-71
8. Myers LS, Morokoff PJ. Physiological and subjective sexual arousal in pre- and postmenopausal women and postmenopausal women taking replacement therapy. Psychophysiology 1986;23:283-292
9. Modelska M, Cummings S. Female sexual dysfunction in postmenopausal women: Systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003;188:286-293
10. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-343
11. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47:339-351
12. Dennerstein L, Burrows GD, Wood C, Hyman G. Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol 1980;56:316-322
13. Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause 2003;10:45-52
14. Natale V, Albertazzi P, Zini M, Di Micco R. Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations. BJOG 2001;108:286-290
15. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854
16. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79:1341-1352
17. Davis SR. When to suspect androgen deficiency other than at menopause. Fertil Steril 2002;77:S68-S71
18. Guay AT. Screening for androgen deficiency in women: methodological and interpretive issues. Fertil Steril 2002;77: S83-S88
19. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 2003;10:390-398
20. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998;43:847-856
21. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688
22. Gracia C, Sammel MD, Freeman EW, Liu L, Hollander L, Nelson DB. Predictors of decreased libido in women during the late reproductive years. Menopause 2004;11:144-150
23. Spark RF. Dehydroepiandrosterone: a springboard hormone for female sexuality. Fertil Steril 2002;77:S19-S25
24. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-1020
25. Barnhart KT, Freeman E, Grisso JA, et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 1999;84:3896-3902
26. Hackbert L, Heiman JR. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med 2002;11:155-162
27. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999;17:2659-2669
28. Fallowfield L, Fleissig A, Edwards R, et al. Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol 2001;19:1885-1892
29. Shiota A, Igarashi T, Kurose T, Ohno M, Hando T. Reciprocal effects of tamoxifen on hormonal cytology in postmenopausal women. Acta Cytol 2002;46:499-506
30. Modugno F, Ness RB, Ewing S, Cauley JA. Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis. Obstet Gynecol 2003;101:353-361
31. Strickler R, Stovall DW, Merritt D, Shen W, Wong M, Silfen SL. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol 2000;96:359-365
32. Voss S, Quail D, Dawson A, et al. A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life. BJOG 2002;109:874-885
33. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41
34. Castelo-Branco C, Vicente JJ, Figueras F, et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34:161-168
35. Kaplan HS. The New Sex Therapy: Active Treatment of Sexual Dysfunctions. New York: Brunner/Mazel; 1974
36. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 2001;98:350-353